Signos Unveils FDA-Cleared Glucose Monitoring Solution for Metabolic Health

Signos has launched the Signos Glucose Monitoring System, reportedly the first U.S. Food and Drug Administration-cleared, over-the-counter glucose monitoring system for weight management. 

Signos is attempting to put metabolic health back into the hands of individuals. By integrating Stelo by Dexcom glucose biosensor with an artificial intelligence (AI)-powered platform for deciphering unique metabolisms, Signos enables people to see the ways food choices, timing, activity, stress, and even sleep affect their bodies in real time—equipping them with the information required to take control of their health and make decisions backed by their own biology.

“This is more than a product launch—it’s a mission,” Signos Founder/CEO Sharam Fouladgar-Mercer said. “Everyone deserves access to insights that help them live healthier, longer, more vibrant lives. Signos isn’t just about data; it’s about giving people ownership over their health and weight journeys in a way never before seen.”

Key features and purpose-driven benefits include:

• Igniting the Metabolic Movement with Personalized Data: By tapping into the body’s own signals, Signos equips individuals with tools to improve sleep, manage weight, and reduce the risk of chronic disease—not through restriction, but through understanding. 
• Personalized, AI-Driven Insights: Signos translates glucose fluctuations into easy-to-follow, personalized recommendations—transforming raw data into actionable guidance for building healthier everyday habits.
• Total Body Intelligence: Signos helps users understand how their bodies respond to meals, workouts, sleep, and stress, creating a holistic picture of personal health.
• Expert Metabolic Monitoring: Signos removes barriers and puts powerful glucose insights into the hands of millions without the need for prescriptions, inflated prices, or hidden hoops. It’s real-time metabolic health, made truly accessible.

The need for accessible, effective metabolic health solutions has never been greater. With 73.6% of U.S. adults classified as overweight or obese, 88% of Americans classified as metabolically unhealthy, and global diabetes diagnoses projected to reach 1.3 billion by 2050, Signos claims it offers a proactive solution grounded in science and is changing the trajectory of metabolic health by intervening early and guiding users toward meaningful, lasting lifestyle changes. The company aims to help millions monitor their metabolic health and build better habits by leveraging insights based on glucose, the body’s primary energy source.

“I’ve been using Signos for years now and no matter my mental ups and downs it is there to keep me in reality,” actress/advisor Raven-Symoné stated. “The reality is things change, levels change, but if you keep an eye on the overall picture you can keep your health in the green. Signos gives me the confidence to enjoy life while being mindful of my body and what it needs.”

Signos is currently available, offering individuals a way to monitor glucose, unlock personalized insights, and take control of their metabolism to build a sustainably healthier life—all from the convenience of their smartphone.

Launched in 2018, Signos Inc. aims to eliminate obesity by igniting the metabolic health movement. Powered by a continuous glucose monitor (CGM), the company’s mobile AI-driven system offers personalized insights into the ways in which food, movement, sleep, stress, and more affect each unique body, enabling people to seize their health. Founded by experts in data science, AI, and behavioral design, the company is committed to building technology that drives better health outcomes.